Evidence map›Paper›PMID 41708739›Full record

ArticleScientific reports2026

Exploring the impact of human pluripotent stem cell heterogeneity on corneal limbal stem cell differentiation outcomes.

Sonja Harjuntausta, Meri Vattulainen, Soile Nymark, Heli Skottman

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sonja HarjuntaustaEye regeneration group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Meri VattulainenEye regeneration group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Soile NymarkBiophysics of the Eye - research group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Heli SkottmanEye regeneration group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. heli.skottman@tuni.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Differentiation of limbal stem cells (LSCs) from human pluripotent stem cells (hPSCs) shows promise for treating bilateral limbal stem cell deficiency. However, variation in hPSCs can compromise cell production protocols and increase unwanted heterogeneity. We hypothesize that intrinsic differences among hPSC lines affect their efficiency and consistency in LSC differentiation. Several hPSC lines were differentiated towards LSCs, and the process was analyzed in different timepoints using real-time qPCR (RT-qPCR) and immunofluorescence (IF) to assess differentiation efficiency. Flow cytometry (FC) was also used to quantify protein expression in the differentiated LSCs. Interestingly, variations in BMP4, LEF1, PAX6, and TGFB1 gene expressions, key factors in corneal epithelium induction, were high even in well-differentiating hPSC lines. Some batches failed to upregulate PAX6 and developed a fibroblastic, mesenchymal morphology, associated with elevated TGFB1 expression. This elevation correlated with fewer cells expressing LSC markers in later differentiation stages. FC results showed similar protein expression variation between lines and batches. These findings highlight the need for further optimization and quality control to ensure reliable production of homogeneous starting material for LSC differentiation.

Indexed as

Cell DifferentiationLimbus CorneaePluripotent Stem CellsBone Morphogenetic Protein 4Cell LineHumansLimbal Stem CellsPAX6 Transcription FactorTransforming Growth Factor beta1Bone Morphogenetic Protein 4PAX6 protein, humanPAX6 Transcription FactorTransforming Growth Factor beta1CorneaDifferentiationHuman pluripotent stem cellsLimbal stem cells

Identifiers

PMID41708739
PMCPMC13004974

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.